Jean-Jacques Mourad: Cohort Study Insights on Aspirin Use in Patients with Horton’s Disease
Jean-Jacques Mourad, Head of Internal Medicine at Franco-British Hospital, shared a post on LinkedIn about a recent article by Maxime Beydon, published in JAMA Network Open, adding:
“When well-constructed and properly analyzed cohort studies provide answers to the gray areas left by randomized trials…
All my sincere congratulations to the French authors of this work, which allows us to weigh a little more clearly the pros and cons of aspirin in patients treated for a Horton’s.”
Title: Low-Dose Aspirin for Cardiovascular Disease Primary Prevention in Patients With Giant Cell Arteritis
Authors: Maxime Beydon, David Hajage, Alexis F. Guédon, Fabrice Carrat, Raphaèle Seror, Florence Tubach
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 22, 2026, 14:45Seyed Mehrab Safdari: Prenatal Diagnosis in Hemophilia – Two Decades of Progress and Remaining Challenges
-
Oct 22, 2026, 14:39Mahmoud Abdelnabi: Evaluating the Evidence on Elevated Lp(a) and VTE Before Clinical Translation
-
Oct 22, 2026, 14:34David McIntosh: Fundamental Flaws in National Blood Systems Are Root Causes of Failure
-
Oct 22, 2026, 14:32Aurelio Maggio: Bridging Scientific Progress and Equitable Access to SCD Care in Sub-Saharan Africa
-
Oct 22, 2026, 14:26Khaled Musallam: Longevity and Healthy Aging in Thalassemia
-
Oct 22, 2026, 14:26Deise Catamo Vaz: Two Years of Growth and a New Way of Seeing the World of Stroke
-
Oct 22, 2026, 14:24Yara Mohamed: A Silent Killer Plots his Victim’s Death Over Years
-
Oct 22, 2026, 14:19Shailendra Singh: Two Different Pulmonary Embolism Cases, One Critically Important Lesson
-
Oct 22, 2026, 14:14Caitlin Raymond: Estimating Infection Rates After Therapeutic Plasma Exchange in a Large Real-World Population